• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受体外膜肺氧合治疗的新生儿的咪达唑仑血浆浓度。

Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation.

作者信息

Mulla Hussain, Lawson Graham, Peek Giles J, Firmin R K, Upton David R

机构信息

University Hospitals of Leicester-De Montfort University, England.

出版信息

ASAIO J. 2003 Jan-Feb;49(1):41-7. doi: 10.1097/00002480-200301000-00007.

DOI:10.1097/00002480-200301000-00007
PMID:12558306
Abstract

Drug disposition is affected during extracorporeal membrane oxygenation (ECMO). This study investigates the dose-concentration relationship of midazolam in neonates requiring ECMO during continuous infusion into the circuit (extracorporeally; n = 10) and intravenously (n = 10). Data on hourly doses and sedation scores were collected for 120 hours. Plasma concentrations were analyzed at times 0, 2, 4, 6, 12, 18, and 24, and every 12 hours thereafter. Both groups were clinically similar. Mean (standard deviation) dose for all patients was 250 (185) microg/kg/h, four times greater than previously reported. Doses administered in the first 24 hours were significantly greater extracorporeally [361 (300)] compared with intravenous [258 (190) microg/kg/h, p < 0.001]. Mean (standard deviation) plasma concentrations in all patients at 24, 48, and 72 hours were 1.4 (0.9), 1.8 (1.2), and 2.6 (1.8) microg/ml, respectively. Satisfactory sedation levels were achieved in all patients. Comparison of the actual observed with predicted (simulated) midazolam concentrations suggested significant attenuation of plasma levels during the first 24 hours of ECMO. However, at 48 hours, observed concentrations exceeded those predicted, suggesting accumulation. We conclude that in the first 24 hours of ECMO, because of an expanded circulating volume and sequestration by the circuit, significantly more midazolam is required to achieve adequate sedation. Subsequently, and because of circuit saturation, maintenance doses should be reduced.

摘要

体外膜肺氧合(ECMO)期间药物处置会受到影响。本研究调查了咪达唑仑在需要ECMO的新生儿中,经体外回路持续输注(体外;n = 10)和静脉输注(n = 10)时的剂量-浓度关系。收集了120小时的每小时剂量和镇静评分数据。在0、2、4、6、12、18和24小时以及此后每12小时分析血浆浓度。两组在临床上相似。所有患者的平均(标准差)剂量为250(185)μg/kg/h,是先前报道的四倍。与静脉输注[258(190)μg/kg/h,p < 0.001]相比,前24小时体外给药剂量[361(300)]显著更高。所有患者在24、48和72小时的平均(标准差)血浆浓度分别为1.4(0.9)、1.8(1.2)和2.6(1.8)μg/ml。所有患者均达到了满意的镇静水平。实际观察到的与预测(模拟)的咪达唑仑浓度比较表明,在ECMO的前24小时血浆水平显著衰减。然而,在48小时时,观察到的浓度超过了预测值,表明有蓄积。我们得出结论,在ECMO的前24小时,由于循环容量扩大和回路中的隔离作用,需要显著更多的咪达唑仑才能达到充分镇静。随后,由于回路饱和,维持剂量应减少。

相似文献

1
Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的新生儿的咪达唑仑血浆浓度。
ASAIO J. 2003 Jan-Feb;49(1):41-7. doi: 10.1097/00002480-200301000-00007.
2
Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.新生儿脉管外膜氧合期间咪达唑仑及其代谢物的群体药代动力学。
Clin Pharmacokinet. 2010 Jun;49(6):407-19. doi: 10.2165/11319970-000000000-00000.
3
Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation.
Anesthesiology. 2003 Aug;99(2):275-82. doi: 10.1097/00000542-200308000-00008.
4
Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.在用人全血预充的体外膜肺氧合回路中进行丙泊酚、咪达唑仑、万古霉素和环孢素的治疗药物监测。
Crit Care. 2015 Feb 12;19(1):40. doi: 10.1186/s13054-015-0772-5.
5
Factors Affecting the Absorption of Midazolam to the Extracorporeal Membrane Oxygenation Circuit.影响咪达唑仑向体外膜肺氧合回路吸收的因素。
Acta Med Okayama. 2019 Apr;73(2):101-107. doi: 10.18926/AMO/56645.
6
Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure.接受体外膜肺氧合治疗呼吸和心肺衰竭的患者镇静需求增加。
Anaesth Intensive Care. 2012 Jul;40(4):648-55. doi: 10.1177/0310057X1204000411.
7
Sedation Practices of Neonates Receiving Extracorporeal Membrane Oxygenation.接受体外膜肺氧合的新生儿镇静实践。
ASAIO J. 2020 May;66(5):559-564. doi: 10.1097/MAT.0000000000001043.
8
Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.大型血管手术后镇静的优化:咪达唑仑持续输注的双盲研究
Can J Anaesth. 1994 Sep;41(9):782-93. doi: 10.1007/BF03011584.
9
A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.一项安慰剂和咪达唑仑对照的 I 期单递增剂量研究,评估雷米唑仑(CNS 7056)的安全性、药代动力学和药效学:第二部分。群体药代动力学和药效学建模与模拟。
Anesth Analg. 2012 Aug;115(2):284-96. doi: 10.1213/ANE.0b013e318241f68a. Epub 2012 Jan 16.
10
Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.重症监护病房患者持续输注劳拉西泮与咪达唑仑的比较:使用劳拉西泮进行镇静更易于管理且更具成本效益。
Crit Care Med. 1999 Aug;27(8):1461-5. doi: 10.1097/00003246-199908000-00009.

引用本文的文献

1
Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.儿童连续肾脏替代治疗中常用药物的药代动力学:当前文献的系统评价。
Clin Pharmacokinet. 2022 Feb;61(2):189-229. doi: 10.1007/s40262-021-01085-z. Epub 2021 Nov 30.
2
Midazolam Exposure Impedes Oligodendrocyte Development via the Translocator Protein and Impairs Myelination in Larval Zebrafish.咪达唑仑暴露通过转位蛋白阻碍少突胶质细胞发育并损害斑马鱼幼体的髓鞘形成。
Mol Neurobiol. 2022 Jan;59(1):93-106. doi: 10.1007/s12035-021-02559-8. Epub 2021 Oct 9.
3
Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.
建立一种 SWATH 毛细管 LC-MS/MS 方法,用于同时进行新生儿血浆的治疗药物监测和非靶向代谢组学分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Aug 1;1179:122865. doi: 10.1016/j.jchromb.2021.122865. Epub 2021 Jul 27.
4
A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.接受体外膜肺氧合治疗患者伏立康唑暴露情况的大型回顾性评估
Microorganisms. 2021 Jul 20;9(7):1543. doi: 10.3390/microorganisms9071543.
5
Sedative and Analgesic Pharmacokinetics During Pediatric ECMO.小儿体外膜肺氧合期间的镇静和镇痛药物动力学
J Pediatr Pharmacol Ther. 2020;25(8):675-688. doi: 10.5863/1551-6776-25.8.675. Epub 2020 Nov 13.
6
Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review.接受体外膜肺氧合治疗的危重症儿科患者的药代动力学改变:一项系统评价
Front Pediatr. 2020 Jun 26;8:260. doi: 10.3389/fped.2020.00260. eCollection 2020.
7
Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge.新生儿体外膜肺氧合中的药物处置与药物治疗:从零散数据到综合知识
Front Pediatr. 2019 Sep 3;7:360. doi: 10.3389/fped.2019.00360. eCollection 2019.
8
Dexmedetomidine extraction by the extracorporeal membrane oxygenation circuit: results from an in vitro study.体外膜肺氧合回路中右美托咪定的提取:一项体外研究的结果。
Perfusion. 2020 Apr;35(3):209-216. doi: 10.1177/0267659119868062. Epub 2019 Aug 21.
9
Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.小儿静脉-静脉体外膜肺氧合期间药物的药代动力学
J Thorac Dis. 2018 Mar;10(Suppl 5):S642-S652. doi: 10.21037/jtd.2017.11.02.
10
Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.优化接受体外膜肺氧合治疗患者的药物剂量
J Thorac Dis. 2018 Mar;10(Suppl 5):S629-S641. doi: 10.21037/jtd.2017.09.154.